Endologix, Inc.

In April 2017, Deerfield committed to provide up to $170 million to Endologix, Inc. in a combination of senior secured notes and a working capital facility. Endologix is a marketer and developer of innovative, minimally invasive technologies that provide personalized treatments to patients suffering from Abdominal Aortic Aneurysms (AAA).